Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2013
Collaborator : Scientific committee
Authors: Alexis Astruc, Bruno Halioua, Jean Zetlaoui, Meryem Harrizi, Alexis Bombezin–Domino, Lise Radoszycki
Patients with Chronic Medical Conditions (CMC) require regular access to healthcare professionals and have to take long-term treatments. The COVID-19 pandemic may affect their clinical outcomes.
Objective: Evaluate the impact of the COVID-19 epidemic on patients with CMC in Europe.
